...
首页> 外文期刊>Infection and immunity >Effect of Skin Barrier Disruption on Immune Responses to Topically Applied Cross-Reacting Material, CRM197, of Diphtheria Toxin
【24h】

Effect of Skin Barrier Disruption on Immune Responses to Topically Applied Cross-Reacting Material, CRM197, of Diphtheria Toxin

机译:皮肤屏障破坏对白喉毒素局部应用交叉反应材料CRM197免疫反应的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The high accessibility of the skin and the presence of immunocompetent cells in the epidermis makes this surface an attractive route for needle-free administration of vaccines. However, the lining of the skin by the stratum corneum is a major obstacle to vaccine delivery. In this study we examined the effect of skin barrier disruption on the immune responses to the cross-reacting material CRM197, a nontoxic mutant of diphtheria toxin (DTx) that is considered as a vaccine candidate. Application of CRM197, together with cholera toxin (CT), onto the tape-stripped skin of mice elicited antibody responses that had anti-DTx neutralizing activity. Vaccine delivery onto mildly ablated skin or intact skin did not elicit any detectable anti-CRM197 antibodies. Mice immunized with CRM197 alone onto the tape-stripped skin mounted a vigorous antigen-specific proliferative response. In contrast, the induction of cellular immunity after CRM197 deposition onto mildly ablated or intact skin was adjuvant dependent. Furthermore, epidermal cells were activated and underwent apoptosis that was more pronounced when the stratum corneum was removed by tape stripping. Overall, these findings highlight the potential for transcutaneous delivery of CRM197 and establish a correlation between the degree of barrier disruption and levels of antigen-specific immune responses. Moreover, these results provide the first evidence that the development of a transcutaneous immunization strategy for diphtheria, based on simple and practical methods to disrupt the skin barrier, is feasible.
机译:皮肤的高可及性和表皮中免疫功能细胞的存在使该表面成为无针疫苗接种的有吸引力的途径。然而,角质层的皮肤衬里是疫苗递送的主要障碍。在这项研究中,我们研究了皮肤屏障破坏对交叉反应物质CRM 197 的免疫反应的影响,该物质是白喉毒素(DTx)的无毒突变体,被认为是候选疫苗。将CRM 197 与霍乱毒素(CT)一起应用在剥离胶带的小鼠皮肤上,可产生具有抗DTx中和活性的抗体反应。将疫苗输送到轻度消融的皮肤或完整的皮肤上不会引起任何可检测的抗CRM 197 抗体。单独用CRM 197 免疫的小鼠在剥离胶带的皮肤上产生了强烈的抗原特异性增殖反应。相反,CRM 197 沉积到轻度消融或完整皮肤上后诱导细胞免疫是佐剂依赖性的。此外,表皮细胞被激活并发生凋亡,这在通过胶带剥离去除角质层时更为明显。总体而言,这些发现凸显了CRM 197 的经皮递送潜力,并在屏障破坏程度与抗原特异性免疫反应水平之间建立了相关性。而且,这些结果提供了第一个证据,表明基于简单而实用的方法来破坏皮肤屏障的白喉透皮免疫策略的开发是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号